首页 › 基金 › Flagship Pioneering, LLC › MRNA
Flagship Pioneering, LLC 对 MRNA 的持仓历史
MODERNA INC · 医疗保健
Flagship Pioneering, LLC 在 Q3 2026 的 13F 申报中披露持有 MRNA(MODERNA INC)4,632,149 股,市值约 US$892.0M,约占其申报组合的 45.62%,在其申报持仓中市值排名第 2 位。 Flagship Pioneering, LLC 最近 13 个申报季度中有 13 个季度披露了 MRNA 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Flagship Pioneering, LLC 对 MRNA 的持仓演变
Flagship Pioneering, LLC 于 Q3 2023 首次披露 MRNA 持仓:9,666,038 股(约 US$998.4M)。 该持仓在 Q1 2024 达到峰值 9,666,038 股,市值约 US$1.03B。 在 13 次申报中,Flagship Pioneering, LLC 0 次增持、1 次减持、11 次保持不变。 最近一期申报(Q3 2026)显示持股 4,632,149 股、市值约 US$892.0M。 持仓曾出现大幅变动:Q2 2024 减持约 52% (随后一个季度股价下跌 44%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 9.67M | $998.41M | 新进 |
| Q4 2023 | 9.67M | $961.29M | 持有 |
| Q1 2024 | 9.67M | $1.03B | 持有 |
| Q2 2024 | 4.63M | $550.07M | 减持 |
| Q3 2024 | 4.63M | $309.57M | 持有 |
| Q4 2024 | 4.63M | $192.60M | 持有 |
| Q1 2025 | 4.63M | $131.32M | 持有 |
| Q2 2025 | 4.63M | $127.80M | 持有 |
| Q3 2025 | 4.63M | $119.65M | 持有 |
| Q4 2025 | 4.63M | $136.60M | 持有 |
| Q1 2026 | 4.63M | $235.31M | 持有 |
| Q2 2026 | 4.63M | $324.39M | 持有 |
| Q3 2026 | 4.63M | $892.01M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 MRNA 与 13F 数据
MRNA(MODERNA INC)属于医疗保健行业。我们追踪的基金中还有 46 只申报持有 MRNA,申报仓位最大的包括:富达投资(FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford (US$2.20B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MRNA 的基金
- 富达投资(FMR) 58.96M 股 · $11.35B · Q3 2026
- Capital World Investors 22.64M 股 · $4.36B · Q3 2026
- Baillie Gifford 11.44M 股 · $2.20B · Q3 2026
- Theleme Partners LLP 6.66M 股 · $1.28B · Q3 2026
- IMC-Chicago, LLC 3.07M 股 · $590.92M · Q3 2026
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 2.42M 股 · $466.58M · Q3 2026
- Merck & Co., Inc. 2.31M 股 · $444.49M · Q3 2026
- BANQUE PICTET & CIE SA 2.15M 股 · $414.27M · Q3 2026
- a16z Perennial Management, L.P. 1.52M 股 · $292.57M · Q3 2026
- PERCEPTIVE ADVISORS LLC 1.40M 股 · $269.60M · Q3 2026
- BAMCO INC /NY/ 1.39M 股 · $267.88M · Q3 2026
- Douglas Lane & Associates, LLC 1.16M 股 · $223.56M · Q3 2026
更多关于 Flagship Pioneering, LLC
常见问题
How long has Flagship Pioneering, LLC held MRNA?
Flagship Pioneering, LLC has disclosed MRNA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Flagship Pioneering, LLC's current position in MRNA?
As of Q3 2026, Flagship Pioneering, LLC holds 4.63M shares of MRNA (MODERNA INC), valued at $892.01M, representing 45.62% of its reported portfolio and ranking #2.
Has Flagship Pioneering, LLC been buying or selling MRNA?
In the latest 13F filing (Q3 2026), Flagship Pioneering, LLC held unchanged its position in MRNA. The position peaked in Q1 2024 at 9.67M shares.
Which other funds hold MRNA?
Other major institutional holders of MRNA include 富达投资(FMR), Capital World Investors, Baillie Gifford, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.